Publication | Open Access

Long-term follow-up of the AML97 study for patients aged 60 years and above with acute myeloid leukaemia: a study of the East German Haematology and Oncology Study Group (OSHO)

Hematological MalignancyMedicineEast German HaematologyMixed-phenotype Acute LeukemiaHematologyAcute Myeloid LeukaemiaAdult T-cell Leukemia-lymphomaAml97 StudyOncologyCancer ResearchMyeloid Neoplasia